• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    0.79 Up 0.03(3.67%) Feb 12, 4:00PM EST
    Prev Close:0.76
    Open:0.80
    Bid:0.77 x 500
    Ask:0.78 x 600
    1y Target Est:2.30
    Beta:0.117001
    Next Earnings Date:N/A
    Day's Range:0.75 - 0.82
    52wk Range:0.74 - 2.35
    Volume:62,622
    Avg Vol (3m):382,169
    Market Cap:78.33M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PLXUp 3.67%78.33M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.50
    Quarterly EPS Est (Dec-15) :0.68
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):0.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback